Form 8-K - Current report:
SEC Accession No. 0000950123-99-000101
Filing Date
1999-01-08
Accepted
1999-01-08 00:00:00
Documents
4
Period of Report
1999-01-06
Items
Item 5: Other events
Item 7: Financial statements and exhibits

Document Format Files

Seq Description Document Type Size
1 OSI PHARMACEUTICALS, INC. 8-K 16183
2 FORM OF RIGHTS AGREEMENT EX-4 152144
3 AMENDED AND RESTATED BY-LAWS OF THE COMPANY EX-99.1 21817
4 PRESS RELEASE EX-99.2 5921
  Complete submission text file 0000950123-99-000101.txt   197953
Mailing Address 106 CHARLES LINDBERGH BLVD UNIONDALE NY 11553-3649
Business Address 106 CHARLES LINDBERGH BLVD UNIONDALE NY 11553 5162220023
OSI PHARMACEUTICALS INC (Filer) CIK: 0000729922 (see all company filings)

EIN.: 133159796 | State of Incorp.: DE | Fiscal Year End: 0930
Type: 8-K | Act: 34 | File No.: 000-15190 | Film No.: 99503395
SIC: 2835 In Vitro & In Vivo Diagnostic Substances